Biotech advancements in thymus regeneration, like TECregen’s therapies, show promise in rejuvenating immune function for aging populations, addressing delivery challenges and ethical considerati...
Recent studies reveal GDF3’s role in driving inflammation in aging fat tissue, with new therapies targeting the SMAD2/3 axis showing promise for improving metabolic health and extending healthsp...
